Patent details
990013
Product Name:
Interferonum Alfacon-1
The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
Ok
Cancel
You have not selected any documents
Ok
Basic Information
Publication number:
990013
Type:
Certificate
SPC Type:
Medical
Basic Patent Number:
EP0422697
Status:
Expired Art. 14 (a) of the EC Regulations
Application number:
990013
Procedural language:
Dutch
First Applicant Residence Country:
Marketing Authorization
1
Marketing Authorization Number:
EU/1/98/087/001
Marketing Authorization Type:
EEA
Marketing Authorization Date:
01/02/1999
Marketing Authorization Country:
European Union (EU)
2
Marketing Authorization Number:
EU/1/98/087/002
Marketing Authorization Type:
EEA
Marketing Authorization Date:
01/02/1999
Marketing Authorization Country:
European Union (EU)
3
Marketing Authorization Number:
EU/1/98/087/003
Marketing Authorization Type:
EEA
Marketing Authorization Date:
01/02/1999
Marketing Authorization Country:
European Union (EU)
4
Marketing Authorization Number:
EU/1/98/087/001
Marketing Authorization Type:
National/EU
Marketing Authorization Date:
01/02/1999
Marketing Authorization Country:
European Union (EU)
5
Marketing Authorization Number:
EU/1/98/087/002
Marketing Authorization Type:
National/EU
Marketing Authorization Date:
01/02/1999
Marketing Authorization Country:
European Union (EU)
6
Marketing Authorization Number:
EU/1/98/087/003
Marketing Authorization Type:
National/EU
Marketing Authorization Date:
01/02/1999
Marketing Authorization Country:
European Union (EU)
Dates
Filing date:
26/04/1999
First Marketing Authorization date:
01/02/1999
Grant date:
09/06/1999
Activation date:
25/04/2003
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Registration date:
26/04/1999
SPC/SPC Extension Expiration Date:
24/04/2008
Lapsed By Expiration Date:
25/04/2008
Withdrawal date:
Revocation Date:
Invalidity Date:
Withdrawal Market Authorization Date:
Refusal Date:
Applicant/holder
From:
26/04/1999
Name:
AMGEN INC.
Address:
Amgen Center One Amgen Center Drive, 91320-1789, Thousand Oaks, California, United States of America (US)
Agent
Name:
ir. H.V. Mertens c.s.
From:
26/04/1999
Address:
Exter Polak & Charlouis B.V.
Postbus 3241, 2280 GE, Rijswijk, Netherlands (NL)
To:
Publication
Bulletin
1
Bulletin Heading:
VRV
Journal edition number:
2008/07
Publication date:
01/07/2008
Description:
Lapse or annulment
2
Bulletin Heading:
SPC
Journal edition number:
1999/08
Publication date:
02/08/1999
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)
3
Bulletin Heading:
SPC
Journal edition number:
1999/07
Publication date:
01/07/1999
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)
Filing date
Document type
Document Description
Number of pages
File Type
09/06/1999
Outgoing Correspondence
Outgoing Letter
1
PDF
/3/1/0/0/9/0400990013/docs/990013_3_outgoingcorrespondence19990609.pdf
09/06/1999
Outgoing Correspondence
Outgoing Letter
1
PDF
/3/1/0/0/9/0400990013/docs/990013_5_outgoingcorrespondence19990609.pdf
26/05/1999
General
1
PDF
/3/1/0/0/9/0400990013/docs/990013_1_spc-documents19990526.pdf
26/05/1999
General
1
PDF
/3/1/0/0/9/0400990013/docs/990013_2_spc-documents19990526.pdf
19/05/1999
General
1
PDF
/3/1/0/0/9/0400990013/docs/990013_0_spc-documents19990519.pdf
26/04/1999
Application Form
First filed application form
2
PDF
/3/1/0/0/9/0400990013/docs/990013_4_applicationform19990426.pdf
26/04/1999
Incoming Correspondence Paper
Other
1
PDF
/3/1/0/0/9/0400990013/docs/990013_6_incomingcorrespondencepaper19990426.pdf
26/04/1999
General
7
PDF
/3/1/0/0/9/0400990013/docs/990013_7_spc-documents19990426.pdf
26/04/1999
General
3
PDF
/3/1/0/0/9/0400990013/docs/990013_8_spc-documents19990426.pdf